Scott Gottlieb, MD, commissioner of the Food and Drug Administration, is resigning from his position, effective April 5th.   Dr. Gottlieb became commissioner in May 2017, and during his tenure, worked to foster competition and reduce the cost and availability of both brand and generic medicines. In his first year as commissioner, a record number of new and generic drugs were approved. Dr. Gottlieb served as FDA Deputy Commissioner for Medical and Scientific Affairs from 2005-2007, and as...